Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.
Press releases published on April 7, 2025

inGroup Escala en la Lista DSN Global 100 con Ingresos Récord
GUAYNABO, Puerto Rico, April 07, 2025 (GLOBE NEWSWIRE) -- inGroup International se enorgullece de anunciar su clasificación como la 39ª empresa de venta directa más grande del mundo, según la recientemente publicada lista Direct Selling News (DSN) 100 de …

XTL Names Mr. Noam Band as its New Chief Executive Officer
Brings a Wealth of Managerial Experience and Track Record RAMAT GAN, ISRAEL, April 07, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”) announced today the appointment of Noam Band as the Company’s …

Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology
Key structural and mechanistic insights into BSEP transporter mutations that lead to improper protein folding and function Findings have potentially broad-ranging clinical relevance for multiple hepatobiliary diseases including progressive familial …

Red Cat Appoints Shawn Webb as President of FlightWave Aerospace
SANTA MONICA, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, today …

Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma
Designations Follow Recent Investigational New Drug (IND) Application Clearance for the RESOLUTION Basket Study of ALLO-329 in Rheumatology Dual CD19/CD70 CAR T Specifically Designed to Enhance Therapeutic Benefit, Expanding Treatment Potential Across a …

ALX Oncology Receives IND Clearance from U.S. FDA for ALX2004, a Novel EGFR-targeted Antibody-drug Conjugate
ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors that was created from ALX Oncology’s proprietary linker-payload platform ALX2004, the company’s first ADC, was fully designed …

Vital Battery Metals Announces Letter of Intent to Acquire the Corvo Uranium Project in the Athabasca Basin
Corvo Uranium Project Highlights More than 29 km of exploration strike length along three strong NE-SW magnetic low trends coincident with EM conductors and cross-cutting faults, providing highly prospective shallow drill targets. Uranium mineralization is …

Oxbridge / SurancePlus to Attend Apex Invest 2025 in Grand Cayman
GRAND CAYMAN, Cayman Islands, April 07, 2025 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (Nasdaq: OXBR) (“Oxbridge Re”), together with its subsidiary SurancePlus, is engaged in the tokenization of Real-World Assets (“RWAs”), initially with tokenized …

Aspargo Labs Expands Global Leadership Team
NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on converting the world's most meaningful medications into liquid oral suspensions for delivery in …

Avicanna Announces its 5th Medical Symposium on Cannabinoid-based Medicine
Bridging Science and Clinical Practice: A Gathering of Thought Leaders in Cannabinoid Medicine Live and Virtual Symposium on June 6th, 2025, at the MaRS Discovery District, Toronto TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or …

Top 10 New Tokens on MEXC Average 4,770% Growth in March
VICTORIA, Seychelles, April 07, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, has released the latest information on the performance of trading operations on the platform, highlighting new milestones and delivering invaluable …

Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity
-- Patients with acquired hypothalamic obesity on setmelanotide therapy (n=81) achieved mean BMI change of -16.5% compared with +3.3% for placebo (n=39) at 52 weeks (p<0.0001) -- -- -19.2% placebo-adjusted BMI reduction achieved in adult patients 18 years …

Pharvaris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Target enrollment achieved in RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, strengthening confidence in clinical timelines Enrollment underway in CHAPTER-3, a pivotal Phase 3 study of deucrictibant for …

Holding(s) in Company
Reykjavík, April 07, 2025 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the …

Telix Appoints Paul Schaffer as Chief Technology Officer
MELBOURNE, Australia and INDIANAPOLIS, April 07, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that is has appointed Dr. Paul Schaffer to the newly created role of Chief Technology …

Bitget Chief of Legal's Open Letter Highlights Expansion and Regulatory Compliance Plans
VICTORIA, Seychelles, April 07, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, has published an open letter by its Chief Legal Officer, Hon Ng, which highlights the exchange's efforts in global regulatory compliance …

CoinEx Research March 2025 Report : Signals from the Side Market
HONG KONG, April 07, 2025 (GLOBE NEWSWIRE) -- CoinEx Research's March 2025 report highlighted a period of sideways movement and volatility in the cryptocurrency market. Bitcoin initially surged to $95,000 following Trump’s announcement of a national …

Perseus Mining March Quarter Report Webinar
Perth, April 07, 2025 (GLOBE NEWSWIRE) -- QUARTERLY REPORT INVESTOR WEBINAR / CALL Perth, Western Australia/April 7, 2025/Perseus Mining Limited (ASX/TSX: PRU) is hosting an investor webinar and conference call to discuss its March 2025 Quarterly Results, …